These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16085415)

  • 21. Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications.
    Jeng AY; Mulder P; Kwan AL; Battistini B
    Can J Physiol Pharmacol; 2002 May; 80(5):440-9. PubMed ID: 12056551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of endothelin-converting enzyme inhibitors for the treatment of cardiovascular diseases.
    Jeng AY
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1076-81. PubMed ID: 14582451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line.
    Dibas A; Prasanna G; Yorio T
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):196-204. PubMed ID: 15969636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and degradation of endothelin-1.
    D'Orléans-Juste P; Plante M; Honoré JC; Carrier E; Labonté J
    Can J Physiol Pharmacol; 2003 Jun; 81(6):503-10. PubMed ID: 12839262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.
    Inguimbert N; Poras H; Teffo F; Beslot F; Selkti M; Tomas A; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2001-5. PubMed ID: 12113828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor induces endothelin-1 production via matrix metalloproteinase-2 rather than endothelin-converting enzyme-1.
    Lee KJ; Kim MK; Park YH; Seol HJ; Lim JE; Lee JN; Oh MJ
    Hypertens Pregnancy; 2007; 26(2):189-99. PubMed ID: 17469009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1.
    Firooznia F; Gude C; Chan K; Tan J; Fink CA; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3059-62. PubMed ID: 12372501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of substrate specificity of a new peptide substrate of endothelin converting enzyme].
    Gureeva TA; Kugaevskaia EV; Pozdnev VF; Prozorovskiĭ VN; Eliseeva IuE; Solov'eva NI
    Biomed Khim; 2007; 53(2):172-80. PubMed ID: 17639718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.
    Gagnidze K; Sachchidanand ; Rozenfeld R; Mezei M; Zhou MM; Devi LA
    J Med Chem; 2008 Jun; 51(12):3378-87. PubMed ID: 18507370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halistanol disulfate B, a novel sulfated sterol from the sponge Pachastrella sp.: inhibitor of endothelin converting enzyme.
    Patil AD; Freyer AJ; Breen A; Carte B; Johnson RK
    J Nat Prod; 1996 Jun; 59(6):606-8. PubMed ID: 8786367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of an oral endothelin converting enzyme inhibitor on rat detrusor function after outlet obstruction.
    Schröder A; Tajimi M; Matsumoto H; Schröder C; Brands M; Andersson KE
    J Urol; 2004 Sep; 172(3):1171-4. PubMed ID: 15311064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle.
    Bihovsky R; Levinson BL; Loewi RC; Erhardt PW; Polokoff MA
    J Med Chem; 1995 Jun; 38(12):2119-29. PubMed ID: 7783143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
    Emoto N; Raharjo SB; Isaka D; Masuda S; Adiarto S; Jeng AY; Yokoyama M
    Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.
    Johnson GD; Ahn K
    Anal Biochem; 2000 Nov; 286(1):112-8. PubMed ID: 11038281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
    Yap EY; Battistini B; McKay KO
    Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition.
    Porter KE; Dickinson T; London NJ
    J Vasc Surg; 2001 Sep; 34(3):548-54. PubMed ID: 11533610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of endothelin-converting enzyme inhibitors using cultured cells.
    Corder R
    Methods Mol Biol; 2002; 206():147-64. PubMed ID: 12152225
    [No Abstract]   [Full Text] [Related]  

  • 40. Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases.
    Daull P; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):247-56. PubMed ID: 17878751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.